Guided Therapeutics (GTHP) Current Deferred Revenue (2010 - 2025)
Guided Therapeutics recorded quarterly Current Deferred Revenue of $189000.0 in Q4 2025, down 72.58% quarter-over-quarter from $689318.0 in Q3 2025, and down 77.74% year-over-year from $848917.0 in Q4 2024.
Guided Therapeutics' Current Deferred Revenue history runs 16 years deep, the most recent figure standing at $189000.0 for Q4 2025.
- In Q4 2025, Current Deferred Revenue fell 77.74% year-over-year to $189000.0; the TTM figure through Dec 2025 stood at $189000.0 (down 77.74% YoY), while the FY2025 annual figure was $189000.0, down 77.74% from the prior year.
- Current Deferred Revenue came in at $189000.0 for Q4 2025 at Guided Therapeutics, down from $689318.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $278.0 million in Q3 2021 to a low of $62000.0 in Q1 2021.
- A 5-year average of $14.4 million and a median of $511050.5 in 2022 frame the typical range for Current Deferred Revenue.
- Across the five-year window, Current Deferred Revenue surged 661804.76% in 2021 and sank 99.82% in 2022, its largest moves.
- Guided Therapeutics' Current Deferred Revenue stood at $337315.0 in 2021, then surged by 50.93% to $509101.0 in 2022, then dropped by 16.67% to $424225.0 in 2023, then surged by 100.11% to $848917.0 in 2024, then slumped by 77.74% to $189000.0 in 2025.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $189000.0, $689318.0, and $679318.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 189,000.00 |
| Sep 30, 2025 | 689,318.00 |
| Jun 30, 2025 | 679,318.00 |
| Mar 31, 2025 | 670,000.00 |
| Dec 31, 2024 | 848,917.00 |
| Sep 30, 2024 | 747,780.00 |
| Jun 30, 2024 | 748,000.00 |
| Mar 31, 2024 | 748,000.00 |
| Dec 31, 2023 | 424,225.00 |
| Sep 30, 2023 | 450,516.00 |
| Jun 30, 2023 | 445,000.00 |
| Mar 31, 2023 | 487,882.00 |
| Dec 31, 2022 | 509,101.00 |
| Sep 30, 2022 | 509,000.00 |
| Jun 30, 2022 | 513,000.00 |
| Mar 31, 2022 | 514,000.00 |
| Dec 31, 2021 | 337,315.00 |
| Sep 30, 2021 | 278.00 Mn |
| Jun 30, 2021 | 62,000.00 |
| Mar 31, 2021 | 62,000.00 |
| Dec 31, 2020 | 42,000.00 |
| Sep 30, 2020 | 42,000.00 |
| Jun 30, 2020 | 101,000.00 |
| Mar 31, 2020 | 101,000.00 |
| Dec 31, 2019 | 101,000.00 |
| Sep 30, 2019 | 98,000.00 |
| Dec 31, 2018 | 66,000.00 |
| Sep 30, 2018 | 35,000.00 |
| Jun 30, 2018 | 17,000.00 |
| Mar 31, 2018 | 28,000.00 |
| Dec 31, 2017 | 21,000.00 |
| Sep 30, 2017 | 156,000.00 |
| Jun 30, 2017 | 93,000.00 |
| Mar 31, 2017 | 30,000.00 |
| Dec 31, 2016 | 34,000.00 |
| Sep 30, 2016 | 69,000.00 |
| Jun 30, 2016 | 41,000.00 |
| Mar 31, 2016 | 66,000.00 |
| Dec 31, 2015 | 217,000.00 |
| Sep 30, 2015 | 33,000.00 |
| Jun 30, 2015 | 36,000.00 |
| Mar 31, 2015 | 24,000.00 |
| Dec 31, 2014 | 24,000.00 |
| Sep 30, 2014 | 10,000.00 |
| Jun 30, 2014 | 28,000.00 |
| Mar 31, 2014 | 6,000.00 |
| Dec 31, 2013 | 14,000.00 |
| Sep 30, 2013 | 37,000.00 |
| Jun 30, 2013 | 4,000.00 |
| Mar 31, 2013 | 65,000.00 |
| Dec 31, 2012 | 40,000.00 |
| Sep 30, 2012 | 582,000.00 |
| Jun 30, 2012 | 772,000.00 |
| Mar 31, 2012 | 228,000.00 |
| Dec 31, 2011 | 453,000.00 |
| Jun 30, 2011 | 655,000.00 |
| Dec 31, 2010 | 332,000.00 |